{"log_id": 3484585472121414492, "direction": 0, "words_result_num": 56, "words_result": [{"probability": {"variance": 0.001591, "average": 0.975618, "min": 0.81402}, "location": {"width": 908, "top": 162, "height": 27, "left": 177}, "words": "小鼠(450mg/Kg/天,PO)、家兔(50mg/Kg/天,SC或IV)和大鼠(50mg/Kg/天,SC)所给予的暴露"}, {"probability": {"variance": 0.005373, "average": 0.972936, "min": 0.583881}, "location": {"width": 674, "top": 197, "height": 27, "left": 120}, "words": "剂量分别为人用剂量的9-18、16-106、11-22倍时,结果均未见致畸作用"}, {"probability": {"variance": 0.000206, "average": 0.996233, "min": 0.903893}, "location": {"width": 909, "top": 231, "height": 26, "left": 177}, "words": "在孕妇中尚无充分的和严格对照的研究,但是有一流行病学调查研究表明,追踪了756名孕妇全身"}, {"probability": {"variance": 2.7e-05, "average": 0.997441, "min": 0.973357}, "location": {"width": 965, "top": 264, "height": 28, "left": 120}, "words": "用药,对婴儿的出生缺陷发生率近似普通人群。但这些数据尚不足以证明其对孕妇和胎儿是安全的。只有"}, {"probability": {"variance": 0.00117, "average": 0.98878, "min": 0.824998}, "location": {"width": 548, "top": 298, "height": 29, "left": 122}, "words": "当本品对胎儿的治疗作用远大于其风险时,才可以考虑服用"}, {"probability": {"variance": 0.006391, "average": 0.982049, "min": 0.470491}, "location": {"width": 911, "top": 331, "height": 29, "left": 176}, "words": "哺乳期妇女用药,本品的乳汁中的浓度为其血药浓度的0.6-4.1倍。当哺乳期妇女服药剂量达到0.3"}, {"probability": {"variance": 0.000342, "average": 0.992816, "min": 0.882979}, "location": {"width": 859, "top": 364, "height": 32, "left": 125}, "words": "g/Kg/天时,该浓度可能累及婴儿,所以哺乳期妇女使用时应谨慎,并只有在必要时才可使用"}, {"probability": {"variance": 0.000645, "average": 0.991728, "min": 0.828777}, "location": {"width": 910, "top": 398, "height": 29, "left": 174}, "words": "致癌性:在大鼠和小鼠的整个生命期,通过管饲给予本品450mg/Kg/天,结果表明,给药组和对照"}, {"probability": {"variance": 3.7e-05, "average": 0.99651, "min": 0.965333}, "location": {"width": 966, "top": 430, "height": 33, "left": 118}, "words": "组发生肿瘤的动物数无统计学意义的显著差别,也不缩短肿瘤发生的潜伏期。小鼠和大鼠的最大血浆浓度"}, {"probability": {"variance": 0.004267, "average": 0.975121, "min": 0.756516}, "location": {"width": 362, "top": 467, "height": 30, "left": 118}, "words": "分别为人用剂量水平的3-6倍和1-2倍"}, {"probability": {"variance": 1.6e-05, "average": 0.997774, "min": 0.988055}, "location": {"width": 135, "top": 503, "height": 26, "left": 182}, "words": "【药代动力学】"}, {"probability": {"variance": 0.011183, "average": 0.925246, "min": 0.706242}, "location": {"width": 236, "top": 538, "height": 24, "left": 175}, "words": "据 Physician' s Desk Re"}, {"probability": {"variance": 0.000324, "average": 0.991452, "min": 0.931767}, "location": {"width": 586, "top": 532, "height": 28, "left": 498}, "words": "(54版)介绍,阿昔洛韦的药代动力学研究结果如下:健康志愿"}, {"probability": {"variance": 0.00011, "average": 0.996347, "min": 0.949142}, "location": {"width": 695, "top": 566, "height": 30, "left": 119}, "words": "者及单纯或带状疱疹患者口服阿昔洛韦的药动学已有评价,其药动学见表1。"}, {"probability": {"variance": 9.2e-05, "average": 0.995008, "min": 0.963095}, "location": {"width": 270, "top": 599, "height": 29, "left": 465}, "words": "表1:阿昔洛韦的药动学特征"}, {"probability": {"variance": 0, "average": 0.999558, "min": 0.999153}, "location": {"width": 44, "top": 641, "height": 23, "left": 120}, "words": "参数"}, {"probability": {"variance": 0, "average": 0.999653, "min": 0.999325}, "location": {"width": 45, "top": 634, "height": 24, "left": 611}, "words": "范围"}, {"probability": {"variance": 5e-06, "average": 0.998085, "min": 0.993281}, "location": {"width": 150, "top": 674, "height": 26, "left": 117}, "words": "血浆蛋白结合率"}, {"probability": {"variance": 1e-06, "average": 0.995341, "min": 0.993882}, "location": {"width": 37, "top": 671, "height": 20, "left": 628}, "words": "33%"}, {"probability": {"variance": 8.1e-05, "average": 0.994353, "min": 0.97291}, "location": {"width": 151, "top": 709, "height": 25, "left": 117}, "words": "血浆消除半衰期"}, {"probability": {"variance": 0.000797, "average": 0.982059, "min": 0.910054}, "location": {"width": 88, "top": 704, "height": 24, "left": 608}, "words": "2.5-3.3h"}, {"probability": {"variance": 0.000124, "average": 0.993632, "min": 0.963994}, "location": {"width": 188, "top": 743, "height": 26, "left": 121}, "words": "平均口服生物利用度"}, {"probability": {"variance": 0.010632, "average": 0.913467, "min": 0.7409}, "location": {"width": 53, "top": 740, "height": 22, "left": 617}, "words": "10-209"}, {"probability": {"variance": 0.001401, "average": 0.988524, "min": 0.839393}, "location": {"width": 359, "top": 773, "height": 32, "left": 119}, "words": "阿昔洛韦生物利用度随剂量增加而升高"}, {"probability": {"variance": 8.1e-05, "average": 0.995727, "min": 0.950238}, "location": {"width": 908, "top": 801, "height": 37, "left": 177}, "words": "交叉设计、单剂量多次口服阿昔洛韦的23名健康志愿者的研究资料表明,阿昔洛韦血药浓度的增加"}, {"probability": {"variance": 4.1e-05, "average": 0.996441, "min": 0.96956}, "location": {"width": 740, "top": 836, "height": 37, "left": 121}, "words": "与给药剂量的增加不一致(见表2),生物利用度的降低取决于剂量而非药物剂型"}, {"probability": {"variance": 0.001218, "average": 0.98648, "min": 0.852516}, "location": {"width": 355, "top": 871, "height": 31, "left": 424}, "words": "表2:稳态下阿昔洛韦的血药峰、谷值"}, {"probability": {"variance": 0.000525, "average": 0.971001, "min": 0.941972}, "location": {"width": 32, "top": 909, "height": 21, "left": 616}, "words": "400"}, {"probability": {"variance": 0, "average": 0.8528, "min": 0.8528}, "location": {"width": 57, "top": 948, "height": 20, "left": 387}, "words": " 83mcg"}, {"probability": {"variance": 0.003127, "average": 0.944082, "min": 0.888163}, "location": {"width": 58, "top": 943, "height": 22, "left": 633}, "words": " 2imcg,"}, {"probability": {"variance": 0.001532, "average": 0.972326, "min": 0.916977}, "location": {"width": 79, "top": 941, "height": 23, "left": 858}, "words": " 1. 6imcg"}, {"probability": {"variance": 0, "average": 0.99706, "min": 0.99706}, "location": {"width": 22, "top": 986, "height": 21, "left": 195}, "words": " gh"}, {"probability": {"variance": 0.035238, "average": 0.827921, "min": 0.599559}, "location": {"width": 46, "top": 983, "height": 19, "left": 426}, "words": " :g/ml"}, {"probability": {"variance": 0.016821, "average": 0.836054, "min": 0.709011}, "location": {"width": 80, "top": 978, "height": 23, "left": 634}, "words": " 63mcg/ml"}, {"probability": {"variance": 0.000474, "average": 0.989903, "min": 0.887782}, "location": {"width": 915, "top": 1004, "height": 40, "left": 171}, "words": "6例受试者的研究结果表明,食物对阿昔洛韦的吸收无影响。因此,阿昔洛韦可与食物同服。仅知"}, {"probability": {"variance": 0.000545, "average": 0.987918, "min": 0.893943}, "location": {"width": 440, "top": 1044, "height": 34, "left": 119}, "words": "本品尿代谢产物为9-(羧氧基)甲基)鸟嘌呤"}, {"probability": {"variance": 0, "average": 0.999796, "min": 0.999447}, "location": {"width": 86, "top": 1083, "height": 25, "left": 177}, "words": "特殊人群"}, {"probability": {"variance": 0.000244, "average": 0.994585, "min": 0.896838}, "location": {"width": 912, "top": 1105, "height": 37, "left": 175}, "words": "肾功能损伤的成人:阿昔洛韦的半衰期与总消除率时间取决于肾功能。肾功能不全的病人应调整剂"}, {"probability": {"variance": 0, "average": 0.995557, "min": 0.995557}, "location": {"width": 24, "top": 1153, "height": 23, "left": 122}, "words": "量"}, {"probability": {"variance": 0.000977, "average": 0.989718, "min": 0.825112}, "location": {"width": 911, "top": 1170, "height": 39, "left": 178}, "words": "儿童:阿昔洛韦一般在儿童体内的药代动力学与成人相似。7个月至7岁的儿童口服300mg/m2和"}, {"probability": {"variance": 0.000301, "average": 0.993049, "min": 0.902268}, "location": {"width": 680, "top": 1205, "height": 38, "left": 123}, "words": "600mg/m2阿昔洛韦,其平均半衰期为2.6小时,范围在(1.59-3.74小时)"}, {"probability": {"variance": 0.000718, "average": 0.991627, "min": 0.831112}, "location": {"width": 914, "top": 1235, "height": 41, "left": 177}, "words": "药物相互作用:丙磺舒与静脉给予阿昔洛韦一起使用时,阿昔洛韦平均半衰期和药时曲线下面积增"}, {"probability": {"variance": 0.000209, "average": 0.994009, "min": 0.943162}, "location": {"width": 297, "top": 1275, "height": 38, "left": 123}, "words": "加,尿排泄减慢,尿清除率降低"}, {"probability": {"variance": 6.1e-05, "average": 0.996053, "min": 0.968846}, "location": {"width": 345, "top": 1311, "height": 28, "left": 185}, "words": "【适应症】本品适用于治疗下列疾病"}, {"probability": {"variance": 0.00422, "average": 0.982392, "min": 0.707291}, "location": {"width": 396, "top": 1341, "height": 35, "left": 176}, "words": "1、急性带状疱疹:用于治疗急性带状疱疹"}, {"probability": {"variance": 4e-05, "average": 0.997208, "min": 0.9686}, "location": {"width": 478, "top": 1376, "height": 30, "left": 178}, "words": "2、生殖器疱疹:用于治疗初发和复发的生殖器疱疹"}, {"probability": {"variance": 0.055011, "average": 0.891441, "min": 0.367051}, "location": {"width": 164, "top": 1325, "height": 78, "left": 898}, "words": "管理专用章"}, {"probability": {"variance": 1.2e-05, "average": 0.993829, "min": 0.989458}, "location": {"width": 44, "top": 1384, "height": 29, "left": 966}, "words": "(5)"}, {"probability": {"variance": 6e-06, "average": 0.997932, "min": 0.991358}, "location": {"width": 226, "top": 1412, "height": 27, "left": 178}, "words": "3、水痘:用于治疗水痘"}, {"probability": {"variance": 2.8e-05, "average": 0.996372, "min": 0.980046}, "location": {"width": 280, "top": 1444, "height": 30, "left": 186}, "words": "【用法用量】口服,剂量如下"}, {"probability": {"variance": 0.001791, "average": 0.980115, "min": 0.868706}, "location": {"width": 150, "top": 1479, "height": 26, "left": 192}, "words": "(一)、常用剂量"}, {"probability": {"variance": 0.002499, "average": 0.983312, "min": 0.685264}, "location": {"width": 770, "top": 1501, "height": 42, "left": 178}, "words": "1、急性带状疱疹:成人每次200-800mg,每4小时1次,一日5次,连用7~10日"}, {"probability": {"variance": 2.6e-05, "average": 0.997096, "min": 0.9847}, "location": {"width": 151, "top": 1547, "height": 24, "left": 179}, "words": "2、生殖器疱疹"}, {"probability": {"variance": 0.001901, "average": 0.979856, "min": 0.882377}, "location": {"width": 155, "top": 1537, "height": 29, "left": 994}, "words": "品监督管理局"}, {"probability": {"variance": 1e-06, "average": 0.997911, "min": 0.996589}, "location": {"width": 129, "top": 1577, "height": 27, "left": 984}, "words": "证明文件"}, {"probability": {"variance": 0.000224, "average": 0.984467, "min": 0.969504}, "location": {"width": 114, "top": 1610, "height": 36, "left": 992}, "words": "骑缝"}], "language": 3}